I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 17 studies | 40% ± 16% | |
| classical monocyte | 11 studies | 31% ± 7% | |
| naive B cell | 10 studies | 20% ± 2% | |
| memory B cell | 9 studies | 20% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 22% ± 4% | |
| B cell | 8 studies | 22% ± 4% | |
| natural killer cell | 7 studies | 19% ± 4% | |
| conventional dendritic cell | 6 studies | 28% ± 14% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 25% ± 3% | |
| dendritic cell | 4 studies | 19% ± 4% | |
| gamma-delta T cell | 4 studies | 16% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 16% ± 0% | |
| monocyte | 3 studies | 24% ± 2% | |
| plasmablast | 3 studies | 31% ± 19% | |
| abnormal cell | 3 studies | 25% ± 6% | |
| mature NK T cell | 3 studies | 19% ± 2% |
